18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.

Croissy-Beaubourg, May 18, 2020, 7:30pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), specializes in in vitro diagnostics and theranostics. Regarding the new Covid-19 testing activity recently initiated, Theradiag confirms that the viremia test developed by…

Continue Reading 18/05/2020 : Theradiag: Approval of a first Covid-19 test, ‘RT-PCR’.

14/05/2020 : Combined General Meeting of May 14, 2020 Second meeting scheduled for June 25, 2020 Update on Covid-19 activities

Croissy-Beaubourg, May 14, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), which specializes in in vitro diagnostics and theranostics, today announces that its Annual General Meeting convened on May 14, 2020 could not validly…

Continue Reading 14/05/2020 : Combined General Meeting of May 14, 2020 Second meeting scheduled for June 25, 2020 Update on Covid-19 activities

22/04/2020 : Theradiag committed to fight Covid-19 and reviews the potential impact for 2020

Croissy-Beaubourg, April 22, 2020, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) specializes in in vitro diagnostics and theranostics. Strategic positioning and decisions on Covid-19 serological testsFollowing the approval of Theradiag’s Board of Directors, at a…

Continue Reading 22/04/2020 : Theradiag committed to fight Covid-19 and reviews the potential impact for 2020